166 related articles for article (PubMed ID: 11162473)
1. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
Orban TI; Olah E
Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
[TBL] [Abstract][Full Text] [Related]
2. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].
Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD
Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716
[TBL] [Abstract][Full Text] [Related]
3. Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms.
Lu M; Arrick BA
Oncogene; 2000 Dec; 19(54):6351-60. PubMed ID: 11175350
[TBL] [Abstract][Full Text] [Related]
4. Real-time PCR quantification of full-length and exon 11 spliced BRCA1 transcripts in human breast cancer cell lines.
Favy DA; Lafarge S; Rio P; Vissac C; Bignon YJ; Bernard-Gallon D
Biochem Biophys Res Commun; 2000 Jul; 274(1):73-8. PubMed ID: 10903898
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.
Vaughn JP; Davis PL; Jarboe MD; Huper G; Evans AC; Wiseman RW; Berchuck A; Iglehart JD; Futreal PA; Marks JR
Cell Growth Differ; 1996 Jun; 7(6):711-5. PubMed ID: 8780884
[TBL] [Abstract][Full Text] [Related]
6. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells.
Lu M; Conzen SD; Cole CN; Arrick BA
Cancer Res; 1996 Oct; 56(20):4578-81. PubMed ID: 8840964
[TBL] [Abstract][Full Text] [Related]
7. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.
Claes K; Poppe B; Machackova E; Coene I; Foretova L; De Paepe A; Messiaen L
Genes Chromosomes Cancer; 2003 Jul; 37(3):314-20. PubMed ID: 12759930
[TBL] [Abstract][Full Text] [Related]
8. RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain.
Campos B; Díez O; Domènech M; Baena M; Balmaña J; Sanz J; Ramírez A; Alonso C; Baiget M
Hum Mutat; 2003 Oct; 22(4):337. PubMed ID: 12955719
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
[TBL] [Abstract][Full Text] [Related]
10. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.
Gudas JM; Li T; Nguyen H; Jensen D; Rauscher FJ; Cowan KH
Cell Growth Differ; 1996 Jun; 7(6):717-23. PubMed ID: 8780885
[TBL] [Abstract][Full Text] [Related]
11. A specific GFP expression assay, penetrance estimate, and histological assessment for a putative splice site mutation in BRCA1.
Southey MC; Tesoriero A; Young MA; Holloway AJ; Jenkins MA; Whitty J; Misfud S; kConFab ; McLachlan SA; Venter DJ; Armes JE
Hum Mutat; 2003 Jul; 22(1):86-91. PubMed ID: 12815598
[TBL] [Abstract][Full Text] [Related]
12. BCoR-L1 variation and breast cancer.
Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer.
Stimpfl M; Tong D; Fasching B; Schuster E; Obermair A; Leodolter S; Zeillinger R
Clin Cancer Res; 2002 Jul; 8(7):2253-9. PubMed ID: 12114428
[TBL] [Abstract][Full Text] [Related]
14. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
Giannini G; Capalbo C; Ristori E; Ricevuto E; Sidoni T; Buffone A; Cortesi E; Marchetti P; Scambia G; Tomao S; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A
Breast Cancer Res Treat; 2006 Nov; 100(1):83-91. PubMed ID: 16847550
[TBL] [Abstract][Full Text] [Related]
15. Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.
Claes K; Vandesompele J; Poppe B; Dahan K; Coene I; De Paepe A; Messiaen L
Oncogene; 2002 Jun; 21(26):4171-5. PubMed ID: 12037674
[TBL] [Abstract][Full Text] [Related]
16. Mutational analysis of the BRCA1-interacting genes ZNF350/ZBRK1 and BRIP1/BACH1 among BRCA1 and BRCA2-negative probands from breast-ovarian cancer families and among early-onset breast cancer cases and reference individuals.
Rutter JL; Smith AM; Dávila MR; Sigurdson AJ; Giusti RM; Pineda MA; Doody MM; Tucker MA; Greene MH; Zhang J; Struewing JP
Hum Mutat; 2003 Aug; 22(2):121-8. PubMed ID: 12872252
[TBL] [Abstract][Full Text] [Related]
17. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
18. Changes in BRCA2 expression during progression of the cell cycle.
Wang SC; Lin SH; Su LK; Hung MC
Biochem Biophys Res Commun; 1997 May; 234(1):247-51. PubMed ID: 9168997
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of a novel BRCA1-null ovarian cancer cell line in response to ionizing radiation.
DelloRusso C; Welcsh PL; Wang W; Garcia RL; King MC; Swisher EM
Mol Cancer Res; 2007 Jan; 5(1):35-45. PubMed ID: 17259345
[TBL] [Abstract][Full Text] [Related]
20. Molecular and in silico analysis of BRCA1 and BRCA2 variants.
Tommasi S; Pilato B; Pinto R; Monaco A; Bruno M; Campana M; Digennaro M; Schittulli F; Lacalamita R; Paradiso A
Mutat Res; 2008 Sep; 644(1-2):64-70. PubMed ID: 18694767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
